Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Sokolov

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Clinical Pharmacology and Therapeutics|December 20, 2024
Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host DiseaseYan-Ou Yang, Victor Sokolov, Alina Volkova, et al.
Diabetes, Obesity & Metabolism|August 20, 2019
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitorsTatiana Yakovleva, Victor Sokolov, Lulu Chu, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug DevelopmentGabriel Helmlinger, Victor Sokolov, Kirill Peskov, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Clinical Pharmacology and Therapeutics|December 20, 2024
Semimechanistic Population PK/PD Modeling of Axatilimab in Healthy Participants and Patients With Solid Tumors or Chronic Graft-Versus-Host DiseaseYan-Ou Yang, Victor Sokolov, Alina Volkova, et al.
Diabetes, Obesity & Metabolism|August 20, 2019
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitorsTatiana Yakovleva, Victor Sokolov, Lulu Chu, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
Quantitative Systems Pharmacology: An Exemplar Model-Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug DevelopmentGabriel Helmlinger, Victor Sokolov, Kirill Peskov, et al.
Pageof 3